4-Methylpentedrone
| 4-MPD | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 205.30 g/mol [1] |
| Predicted LogP | 2.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H19NO |
| IUPAC name | 2-(methylamino)-1-(4-methylphenyl)pentan-1-one |
| SMILES | CCCC(C(=O)C1=CC=C(C=C1)C)NC |
| InChI | InChI=1S/C13H19NO/c1-4-5-12(14-3)13(15)11-8-6-10(2)7-9-11/h6-9,12,14H,4-5H2,1-3H3 |
| InChIKey | AKVKBEDACKJNPO-UHFFFAOYSA-N |
| CAS number | 1373918-61-6 |
| UNII | G83HJ935NV |
| PubChem CID | 124201807 |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 35.8 mg(30x - 26.8%) |
| Common | 35.8 - 40 mg(36x - 32.1%) |
| Strong | 40 - 46.3 mg(18x - 16.1%) |
| Heavy | 46.3 - 50 mg(26x - 23.2%) |
| Extreme | 50 mg +(2x - 1.8%) |
| Intravenous [] | |
|---|---|
| Light | ≤ 19.5 mg(29x - 25.0%) |
| Common | 19.5 - 20 mg(33x - 28.4%) |
| Strong | 20 - 25 mg(27x - 23.3%) |
| Heavy | 25 - 38.6 mg(14x - 12.1%) |
| Extreme | 38.6 mg +(13x - 11.2%) |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
4-Methylpentedrone (also known as 4-Methyl-α-methylamino-valerophenone, 4-methylpentedrone (4-MPD), 1-(4-methylphenyl)-2-methylamino-pentan-1-one, 2-(methylamino)-1-(p-tolyl)pentan-1-one,monohydrochloride, Yec91861, 2-(methylamino)-1-(p-tolyl)pentan-1-one, 1-(4-methylphenyl)-2-(methylamino)pentan-1-one or 1-Pentanone, 2-(methylamino)-1-(4-methylphenyl)-) is a substance of the cathinone class.
Chemistry
Stereochemistry []
4-Methylpentedrone is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
4-Methylpentedrone matches Lipinski's rule of five.Reagents
There are currently 6 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change (foaming) | |
| Mecke | light grey (foaming) | |
| Mandelin | light brown (foaming) | |
| Liebermann | yellow (foaming) | |
| Froehde | no color change (foaming) | |
| Gallic | no color change (foaming) |
Subjective effects []
| 0xea / 4-Methylpentedrone [] | |
|---|---|
Routes:
| |
| a1ko / 4-Methylpentedrone [] | |
|---|---|
Routes:
| |
Experience reports
Legal status []
- Germany: 4-Methylpentedrone is a Neuer psychoaktiver Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: 4-Methylpentedrone is a Class B under the "Misuse of Drugs Act 1971".
See also []
External links []
- 4-Methylpentedrone (Wikipedia)
- 4-Methylpentedrone (PubChem)
- 4-Methylpentedrone (Wikidata)
- 4-Methylpentedrone (ChEBI)
- 4-Methylpentedrone (Common Chemistry)
- 4-Methylpentedrone (EPA DSSTox)
- 4-Methylpentedrone (Probes & Drugs)
- 4-Methylpentedrone (Effect Index)
- 4-Methylpentedrone (UNII)
- 4-Methylpentedrone (Erowid)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 124201807, 4-Methylpentedrone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/124201807
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Methylpentedrone. UNII: G83HJ935NV. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/G83HJ935NV
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 09:13:13 |
| drugspro | ok | 2026-11-20 09:13:09 |
| erowid | ok | 2026-11-20 09:13:12 |
| gsrs | ok | 2026-11-20 09:13:10 |
| hmdb | missing (no HMDB id) | 2026-11-20 09:13:09 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:13:14 |
| pubchem | ok | 2026-11-20 09:13:08 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:13:09 | |
| sider | missing (not in SIDER) | 2026-11-20 09:13:09 |
| structure | ok | 2026-11-20 09:13:09 |
| wikipedia | ok | 2026-11-20 09:13:10 |